Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Global news this morning

<< Previous

Bullboard Posts

Next >>

Comment by LastHurrahon Nov 02, 2022 11:07am

238 Views

Post# 35066271

RE:Global news this morning

Finished the first human trial - two are insulin free. They are looking for another 40 type 1 patients - the news clip this morning isn't available for posting yet (hence the 2021 post). The caveat is that the patients have to be "newly diagnosed" suggesting that it doesn't work for existing longer term Type 1 patients. Treated with a crones drug.

<< Previous

Bullboard Posts

Next >>

AmmPower chosen for Ukraine program to advance clean energy initiatives